Shenglong Chen
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
- Barrier Structure and Function Studies
-
- Intensive Care Unit Cognitive Disorders
Papers in
-
- Inflammasome and immune disorders 4
-
- Cardiac Fibrosis and Remodeling 5
- Cardiac Valve Diseases and Treatments 4
- Co-authors
- Hongke Zeng (14 shared papers)Hongguang Ding (9 shared papers)Wenqiang Jiang (11 shared papers)Xinqiang Liu (9 shared papers)Miaoyun Wen (10 shared papers)Zhonghua Wang (4 shared papers)Yongli Han (4 shared papers)Ya Li (2 shared papers)
- Journals
- European Journal of Pharmacology (2 papers)CNS Neuroscience & Therapeutics (2 papers)Drug Design Development and Therapy (2 papers)Neurochemical Research (1 paper)Annals of Palliative Medicine (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shenglong Chen
43 papers receiving 560 citations
Peers
Comparison fields: 5 of 93
- Neurology 116
- Critical Care and Intensive Care Medicine 59
- Nephrology 56
- Biological Psychiatry 16
- Cardiology and Cardiovascular Medicine 112
Countries citing papers authored by Shenglong Chen
This map shows the geographic impact of Shenglong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglong Chen more than expected).
Fields of papers citing papers by Shenglong Chen
This network shows the impact of papers produced by Shenglong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglong Chen. The network helps show where Shenglong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shenglong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 99 | |
| 2 | 2021 | 87 | |
| 3 | 2017 | 41 | |
| 4 | 2021 | 27 | |
| 5 | 2020 | 27 | |
| 6 | [Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate]. | 2015 | 26 |
| 7 | 2018 | 25 | |
| 8 | 2020 | 25 | |
| 9 | 2009 | 18 | |
| 10 | 2008 | 17 | |
| 11 | 2011 | 17 | |
| 12 | 2010 | 17 | |
| 13 | 2012 | 16 | |
| 14 | 2015 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 12 | |
| 17 | 2021 | 8 | |
| 18 | 2018 | 8 | |
| 19 | 2023 | 7 | |
| 20 | Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling. | 2014 | 7 |
About Shenglong Chen
Shenglong Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology, Surgery and Neurology, having authored 43 papers that have together received 562 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (8 papers), Intensive Care Unit Cognitive Disorders (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Cardiac Fibrosis and Remodeling (5 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Barrier Structure and Function Studies (4 papers), Inflammasome and immune disorders (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). The work is most often cited by research in Neurology (116 citations), Critical Care and Intensive Care Medicine (59 citations), Nephrology (56 citations), Biological Psychiatry (16 citations) and Cardiology and Cardiovascular Medicine (112 citations). Shenglong Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hongke Zeng, Hongguang Ding, Wenqiang Jiang, Xinqiang Liu, Miaoyun Wen, Zhonghua Wang, Yongli Han, Ya Li, Wenhong Zhong and Yunfei Chai. Their work appears in journals such as European Journal of Pharmacology, CNS Neuroscience & Therapeutics, Drug Design Development and Therapy, Neurochemical Research and Annals of Palliative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.